top of page
CLINICAL STUDIES
Kidney transplantation
OPEN ENROLLMENT
Mercury.
A Phase 3 Prospective, Randomized, Multi-center, Open-label, Controlled Trial to Assess the Efficacy and Safety of Cellular Immunotherapy with MDR-101 for Induction of Immune Tolerance in Recipients of HLA-matched, Living Donor Kidney Transplants
â
Funded by Medeor Therapeutics, Inc
â
Read
Read
OPEN ENROLLMENT
A randomized double-blind placebo-controlled study to evaluate the efficacy and safety of CINRYZE® (C1 esterase inhibitor [human]) for the treatment of acute antibody-mediated rejection in kidney transplant patients.
â
Funded by Shire ViroPharma, Inc..
Read
OPEN ENROLLMENT
A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in
Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de novo Kidney Transplant Recipients.
â
Funded by Astellas Pharma Global Development, Inc.
Read
COMPLETED
A Phase 2a, Randomized, Open-Label, Active Control, Multi- Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients
â
Funded by Astellas Pharma Global Development, Inc.
Read results
COMPLETED
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-Seropositive Donor.
Funded by Astellas Pharma Global Development, Inc.
bottom of page